Outcomes research in amyotrophic lateral sclerosis: Lessons learned from the amyotrophic lateral sclerosis clinical assessment, research, and education database

Annals of Neurology

Volumn 65, Issue SUPPL. 1, 2009, Pages

  Miller, Robert G ^a   Anderson, Fred ^b   Brooks, Benjamin Rix ^c   Mitsumoto, Hiroshi ^d   Bradley, Walter G ^e   Ringel, Steven P ^f  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d NEUROLOGICAL INSTITUTE   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIOXIDANT; ATROPINE; BENZATROPINE; CREATINE; GABAPENTIN; GLYCOPYRRONIUM BROMIDE; RILUZOLE; SCOPOLAMINE; TRIHEXYPHENIDYL; VITAMIN;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIAGNOSTIC IMAGING; DIET THERAPY; DISEASE ASSOCIATION; DRUG MEGADOSE; DYSPHAGIA; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH EDUCATION; HUMAN; HYPERSALIVATION; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; OBSERVATIONAL STUDY; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT EDUCATION; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FAILURE; SPEECH THERAPY; SURVIVAL RATE; SYMPTOM; TOTAL QUALITY MANAGEMENT; TRADITIONAL MEDICINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DATABASES, FACTUAL; FEMALE; GULF WAR; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NORTH AMERICA; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; RESEARCH;

EID: 60849087671     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21556     Document Type: Article

References (17)

1. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999;52:1311-1323.
2. Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2007;1:CD001447.
3. Jewitt K, Hughes R. Systematic reviews to help guide clinical practice in neuromuscular disease. J Neurol Neurosurg Psychiatry 2003;74(suppl 2):ii43-ii44.
4. Miller RG, Anderson FA Jr, Bradley WG, et al. The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group. Neurology 2000;54:53-57.
5. Brooks BR. Risk factors in the early diagnosis of ALS: North American epidemiological studies. ALS CARE Study Group. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1(suppl 1):S19-S26.
6. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124(suppl):96-107.
7. Bradley WG, Anderson F, Bromberg M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology 2001;57:500-504.
8. Bradley WG, Anderson F, Gowda N, Miller RG; ALS CARE Study Group. Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:240-244.
9. Arciniegas DB, Topkoff J. The neuropsychiatry of pathologic affect: an approach to evaluation and treatment. Semin Clin Neuropsychiatry 2000;5:290-306.
10. Mitsumoto H, Davidson M, Moore D, et al; ALS CARE Study Group. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:177-185.
11. Aboussouan LS, Khan SU, Meeker DP, et al. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127:450-453.
12. Lechtzin N, Wiener CM, Clawson L, et al. Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5:9-15.
13. Brooks BR, Anderson FA, Gowda N; and the ALS CARE Study Group. Amyotrophic lateral sclerosis (ALS) outcomes in US military veterans compared with non-veterans: neuroepidemiological insights from the ALS CARE Database. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4(suppl 1):114. Abstract P55.
14. Horner RD, Kamins KG, Feussner JR, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2003;61:742-749.
15. Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology 2003;61:750-756.
16. Institute of Medicine of the National Academies. Amyotrophic lateral sclerosis in veterans: A review of the scientific literature. Washington, DC: The National Academies Press; November 10, 2006.
17. Waclawik AJ, Brooks BR, Anderson FA Jr, et al; and the ALS CARE Study Group. Onset of amyotrophic lateral sclerosis (ALS) is delayed, but course is not altered, in ALS patients with pre-existing bone and joint disease: neuroepidemiological insights from the ALS CARE Database. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4(suppl 1):115-116. Abstract P56.